34 results
DEFA14A
REGN
Regeneron Pharmaceuticals, Inc.
17 May 23
Additional proxy soliciting materials
4:04pm
, 3 of whom are women. The Board and the Corporate Governance and Compliance Committee of the Board are actively searching for a new female director … , 4 (or 31%) of whom will be women.
Institutional Shareholder Services Inc.
Glass, Lewis & Co.
May 17, 2023
Current Gender Diversity
DEFA14A
1g3hvlcm12i37w8gyb
26 Apr 19
Additional proxy soliciting materials
4:08pm
8-K
EX-99.1
lobk7v2
10 Mar 11
Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer
12:00am
8-K
EX-99.1
d35e5
13 May 10
Other Events
12:00am
8-K
EX-99.1
517 oex30iig9a
31 Jul 08
Regeneron Reports Second Quarter 2008 Financial and Operating Results
12:00am